China NMPA Product Recall - Cerebrospinal fluid shunt tube and accessories

The National Medical Products Administration (NMPA) issued an announcement on November 30, 2020, regarding a voluntary Class II recall by Medtronic Inc. The recall specifically involves certain models and batches of Cerebrospinal Fluid Shunt Tubes and Accessories. Medtronic (Shanghai) Management Co., Ltd. reported that the primary issue leading to the recall was a persistent manufacturing defect related to the processing auxiliary protective sleeve of these products, which remained present post-production. This voluntary action by Medtronic Inc. is in compliance with regulatory standards and aims to address the identified product quality concern. Detailed information concerning the affected product models, specifications, and batch numbers is available in the accompanying Medical Device Recall Event Report Form, underscoring the company's commitment to patient safety and product integrity under the NMPA's oversight. The Class II recall level indicates a situation where use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.